Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases |
| |
Authors: | Ping Huang Guangwei Chen Weifeng Jin Kunjun Mao Haitong Wan Yu He |
| |
Affiliation: | 1.School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China; (P.H.); (G.C.); (W.J.); (K.M.);2.School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China |
| |
Abstract: | Differential evolution of apoptosis, programmed necrosis, and autophagy, parthanatos is a form of cell death mediated by poly(ADP-ribose) polymerase 1 (PARP1), which is caused by DNA damage. PARP1 hyper-activation stimulates apoptosis-inducing factor (AIF) nucleus translocation, and accelerates nicotinamide adenine dinucleotide (NAD+) and adenosine triphosphate (ATP) depletion, leading to DNA fragmentation. The mechanisms of parthanatos mainly include DNA damage, PARP1 hyper-activation, PAR accumulation, NAD+ and ATP depletion, and AIF nucleus translocation. Now, it is reported that parthanatos widely exists in different diseases (tumors, retinal diseases, neurological diseases, diabetes, renal diseases, cardiovascular diseases, ischemia-reperfusion injury...). Excessive or defective parthanatos contributes to pathological cell damage; therefore, parthanatos is critical in the therapy and prevention of many diseases. In this work, the hallmarks and molecular mechanisms of parthanatos and its related disorders are summarized. The questions raised by the recent findings are also presented. Further understanding of parthanatos will provide a new treatment option for associated conditions. |
| |
Keywords: | parthanatos hallmarks molecular mechanisms related diseases |
|
|